Muscarinic M1 receptor modulation of synaptic plasticity in nucleus accumbens of wild-type and fragile X mice
Daniela N. NeuhoferiD, Olivier LassalleiD, Olivier J. ManzoniiD
Abstract
We investigated how metabotropic Acetylcholine receptors control excitatory synaptic plasticity in the mouse nucleus accumbens core. Pharmacological and genetic approaches revealed that M1 mAChRs trigger multiple and interacting forms of synaptic plasticity. As previously described in the dorsal striatum, moderate pharmacological activation of M1 mAChR potentiated postsynaptic NMDARs. The M1-potentiation of NMDAR masked a previously unknown coincident TRPV1-mediated long-term depression (LTD). In addition, strong pharmacological activation of M1 mAChR induced canonical retrograde LTD, mediated by presynaptic CB1R. In the fmr1-/y mouse model of Fragile X, we found that CB1R but not TRPV1 M1-LTD was impaired. Finally, pharmacological blockade of the degradation of anandamide and 2-arachidonylglycerol, the two principal eCBs restored fmr1-/y LTD to wild type levels. These findings shed new lights on the complex influence of Acetylcholine on excitatory synapses in the nucleus accumbens core and identify new substrates of the synaptic deficits of Fragile X.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 24
- FWCI
- 0.80
- Field percentile
- top 37%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exaggerated NMDA Receptor-Primed Metaplasticity via SK Channel Dysregulation in Fmr1 Knockout Mice
Toshihiro Nomura, Chad Morton, … Anis Contractor·Journal of NeurosciencePeer-reviewed·Apr 29, 2026
- Improvement of Behavioral Deficits in a Mouse Model of Fragile X Syndrome by Restoring α7 nAChR Hypofunction Associated with Aberrant Ly6H Expression
Sarah Goebel, Dylann Cordova-Martinez, … Anna Francesconi·bioRxiv·Nov 1, 2024
- A serotonergic mechanism is involved in the pro-cognitive effect of AM6545 treatment in a mouse model of fragile X syndrome
Lucía de los Reyes‐Ramírez, Araceli Bergadà‐Martínez, … Andrés Ozaita·Translational PsychiatryPeer-reviewed·Aug 20, 2026
- Homeostatic Inhibitory Control of Cortical Hyperexcitability in Fragile X Syndrome
Christian A. Cea-Del Rio, Alexia Nunez-Parra, … Molly M. Huntsman·bioRxiv·Nov 1, 2018
- Non-ionotropic signaling through the NMDA receptor GluN2B carboxy terminal domain drives morphological plasticity of dendritic spines and reverses fragile X phenotypes in mouse hippocampus
Stephanie A. Barnes, Aurore Thomazeau, … Mark F. Bear·bioRxiv·Dec 15, 2024
- Dichotomous Intrinsic Properties of Adult Accumbens Medium Spiny Neurons Vanish in the Fragile X Mouse Model of Autism
Gabriele Giua, Olivier Lassalle, … Olivier J. Manzoni·bioRxiv·Jul 6, 2022